nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadodiamide—Blood creatinine increased—Ifosfamide—germ cell cancer	0.0059	0.0059	CcSEcCtD
Gadodiamide—Renal failure acute—Cisplatin—germ cell cancer	0.00589	0.00589	CcSEcCtD
Gadodiamide—Lung disorder—Methotrexate—germ cell cancer	0.0058	0.0058	CcSEcCtD
Gadodiamide—Phlebitis—Etoposide—germ cell cancer	0.00578	0.00578	CcSEcCtD
Gadodiamide—Anaphylactoid reaction—Cisplatin—germ cell cancer	0.00561	0.00561	CcSEcCtD
Gadodiamide—Acute coronary syndrome—Bleomycin—germ cell cancer	0.0056	0.0056	CcSEcCtD
Gadodiamide—Myocardial infarction—Bleomycin—germ cell cancer	0.00557	0.00557	CcSEcCtD
Gadodiamide—Hyponatraemia—Cisplatin—germ cell cancer	0.00546	0.00546	CcSEcCtD
Gadodiamide—Bronchospasm—Ifosfamide—germ cell cancer	0.00536	0.00536	CcSEcCtD
Gadodiamide—Anaphylactoid reaction—Etoposide—germ cell cancer	0.00514	0.00514	CcSEcCtD
Gadodiamide—Cardiac failure—Etoposide—germ cell cancer	0.0051	0.0051	CcSEcCtD
Gadodiamide—Blood creatinine increased—Cisplatin—germ cell cancer	0.00509	0.00509	CcSEcCtD
Gadodiamide—Ill-defined disorder—Vinblastine—germ cell cancer	0.00488	0.00488	CcSEcCtD
Gadodiamide—Acute coronary syndrome—Ifosfamide—germ cell cancer	0.00479	0.00479	CcSEcCtD
Gadodiamide—Renal failure—Ifosfamide—germ cell cancer	0.00477	0.00477	CcSEcCtD
Gadodiamide—Neuropathy peripheral—Ifosfamide—germ cell cancer	0.00476	0.00476	CcSEcCtD
Gadodiamide—Myocardial infarction—Ifosfamide—germ cell cancer	0.00476	0.00476	CcSEcCtD
Gadodiamide—Malaise—Vinblastine—germ cell cancer	0.00474	0.00474	CcSEcCtD
Gadodiamide—Flushing—Bleomycin—germ cell cancer	0.00473	0.00473	CcSEcCtD
Gadodiamide—Pharyngitis—Dactinomycin—germ cell cancer	0.00472	0.00472	CcSEcCtD
Gadodiamide—Extravasation—Methotrexate—germ cell cancer	0.00471	0.00471	CcSEcCtD
Gadodiamide—Chills—Bleomycin—germ cell cancer	0.00458	0.00458	CcSEcCtD
Gadodiamide—Sweating increased—Cisplatin—germ cell cancer	0.00457	0.00457	CcSEcCtD
Gadodiamide—Convulsion—Vinblastine—germ cell cancer	0.00456	0.00456	CcSEcCtD
Gadodiamide—Discomfort—Vinblastine—germ cell cancer	0.00442	0.00442	CcSEcCtD
Gadodiamide—Flushing—Dactinomycin—germ cell cancer	0.00442	0.00442	CcSEcCtD
Gadodiamide—Hepatic enzyme increased—Methotrexate—germ cell cancer	0.00434	0.00434	CcSEcCtD
Gadodiamide—Hallucination—Ifosfamide—germ cell cancer	0.00434	0.00434	CcSEcCtD
Gadodiamide—Urinary tract disorder—Ifosfamide—germ cell cancer	0.00431	0.00431	CcSEcCtD
Gadodiamide—Urethral disorder—Ifosfamide—germ cell cancer	0.00427	0.00427	CcSEcCtD
Gadodiamide—Chills—Dactinomycin—germ cell cancer	0.00427	0.00427	CcSEcCtD
Gadodiamide—Bronchospasm—Etoposide—germ cell cancer	0.00423	0.00423	CcSEcCtD
Gadodiamide—Visual impairment—Ifosfamide—germ cell cancer	0.0042	0.0042	CcSEcCtD
Gadodiamide—Sweating increased—Etoposide—germ cell cancer	0.00419	0.00419	CcSEcCtD
Gadodiamide—Acute coronary syndrome—Cisplatin—germ cell cancer	0.00413	0.00413	CcSEcCtD
Gadodiamide—Ill-defined disorder—Bleomycin—germ cell cancer	0.00412	0.00412	CcSEcCtD
Gadodiamide—Renal failure—Cisplatin—germ cell cancer	0.00412	0.00412	CcSEcCtD
Gadodiamide—Myocardial infarction—Cisplatin—germ cell cancer	0.0041	0.0041	CcSEcCtD
Gadodiamide—Neuropathy peripheral—Cisplatin—germ cell cancer	0.0041	0.0041	CcSEcCtD
Gadodiamide—Tinnitus—Ifosfamide—germ cell cancer	0.00407	0.00407	CcSEcCtD
Gadodiamide—Flushing—Ifosfamide—germ cell cancer	0.00405	0.00405	CcSEcCtD
Gadodiamide—Melaena—Methotrexate—germ cell cancer	0.00401	0.00401	CcSEcCtD
Gadodiamide—Malaise—Bleomycin—germ cell cancer	0.004	0.004	CcSEcCtD
Gadodiamide—Chills—Ifosfamide—germ cell cancer	0.00391	0.00391	CcSEcCtD
Gadodiamide—Arrhythmia—Ifosfamide—germ cell cancer	0.00389	0.00389	CcSEcCtD
Gadodiamide—Paraesthesia—Vinblastine—germ cell cancer	0.00385	0.00385	CcSEcCtD
Gadodiamide—Ill-defined disorder—Dactinomycin—germ cell cancer	0.00384	0.00384	CcSEcCtD
Gadodiamide—Acute coronary syndrome—Etoposide—germ cell cancer	0.00378	0.00378	CcSEcCtD
Gadodiamide—Chest pain—Bleomycin—germ cell cancer	0.00378	0.00378	CcSEcCtD
Gadodiamide—Myalgia—Bleomycin—germ cell cancer	0.00378	0.00378	CcSEcCtD
Gadodiamide—Renal failure—Etoposide—germ cell cancer	0.00377	0.00377	CcSEcCtD
Gadodiamide—Myocardial infarction—Etoposide—germ cell cancer	0.00376	0.00376	CcSEcCtD
Gadodiamide—Neuropathy peripheral—Etoposide—germ cell cancer	0.00376	0.00376	CcSEcCtD
Gadodiamide—Coma—Methotrexate—germ cell cancer	0.00375	0.00375	CcSEcCtD
Gadodiamide—Discomfort—Bleomycin—germ cell cancer	0.00374	0.00374	CcSEcCtD
Gadodiamide—Malaise—Dactinomycin—germ cell cancer	0.00374	0.00374	CcSEcCtD
Gadodiamide—Urinary tract disorder—Cisplatin—germ cell cancer	0.00371	0.00371	CcSEcCtD
Gadodiamide—Urethral disorder—Cisplatin—germ cell cancer	0.00368	0.00368	CcSEcCtD
Gadodiamide—Pain—Vinblastine—germ cell cancer	0.00367	0.00367	CcSEcCtD
Gadodiamide—Oedema—Bleomycin—germ cell cancer	0.00362	0.00362	CcSEcCtD
Gadodiamide—Anaphylactic shock—Bleomycin—germ cell cancer	0.00362	0.00362	CcSEcCtD
Gadodiamide—Visual impairment—Cisplatin—germ cell cancer	0.00362	0.00362	CcSEcCtD
Gadodiamide—Infection—Bleomycin—germ cell cancer	0.0036	0.0036	CcSEcCtD
Gadodiamide—Feeling abnormal—Vinblastine—germ cell cancer	0.00354	0.00354	CcSEcCtD
Gadodiamide—Myalgia—Dactinomycin—germ cell cancer	0.00353	0.00353	CcSEcCtD
Gadodiamide—Ill-defined disorder—Ifosfamide—germ cell cancer	0.00352	0.00352	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Vinblastine—germ cell cancer	0.00351	0.00351	CcSEcCtD
Gadodiamide—Tinnitus—Cisplatin—germ cell cancer	0.0035	0.0035	CcSEcCtD
Gadodiamide—Flushing—Cisplatin—germ cell cancer	0.00349	0.00349	CcSEcCtD
Gadodiamide—Discomfort—Dactinomycin—germ cell cancer	0.00348	0.00348	CcSEcCtD
Gadodiamide—Malaise—Ifosfamide—germ cell cancer	0.00342	0.00342	CcSEcCtD
Gadodiamide—Urinary tract disorder—Etoposide—germ cell cancer	0.0034	0.0034	CcSEcCtD
Gadodiamide—Abdominal pain—Vinblastine—germ cell cancer	0.00339	0.00339	CcSEcCtD
Gadodiamide—Hypotension—Bleomycin—germ cell cancer	0.00339	0.00339	CcSEcCtD
Gadodiamide—Oedema—Dactinomycin—germ cell cancer	0.00338	0.00338	CcSEcCtD
Gadodiamide—Urethral disorder—Etoposide—germ cell cancer	0.00338	0.00338	CcSEcCtD
Gadodiamide—Infection—Dactinomycin—germ cell cancer	0.00336	0.00336	CcSEcCtD
Gadodiamide—Arrhythmia—Cisplatin—germ cell cancer	0.00336	0.00336	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Bleomycin—germ cell cancer	0.0033	0.0033	CcSEcCtD
Gadodiamide—Convulsion—Ifosfamide—germ cell cancer	0.00329	0.00329	CcSEcCtD
Gadodiamide—Paraesthesia—Bleomycin—germ cell cancer	0.00325	0.00325	CcSEcCtD
Gadodiamide—Dyspnoea—Bleomycin—germ cell cancer	0.00323	0.00323	CcSEcCtD
Gadodiamide—Myalgia—Ifosfamide—germ cell cancer	0.00323	0.00323	CcSEcCtD
Gadodiamide—Chest pain—Ifosfamide—germ cell cancer	0.00323	0.00323	CcSEcCtD
Gadodiamide—Arthralgia—Ifosfamide—germ cell cancer	0.00323	0.00323	CcSEcCtD
Gadodiamide—Renal failure acute—Methotrexate—germ cell cancer	0.00323	0.00323	CcSEcCtD
Gadodiamide—Flushing—Etoposide—germ cell cancer	0.0032	0.0032	CcSEcCtD
Gadodiamide—Discomfort—Ifosfamide—germ cell cancer	0.00319	0.00319	CcSEcCtD
Gadodiamide—Hypersensitivity—Vinblastine—germ cell cancer	0.00316	0.00316	CcSEcCtD
Gadodiamide—Visual disturbance—Methotrexate—germ cell cancer	0.00315	0.00315	CcSEcCtD
Gadodiamide—Pain—Bleomycin—germ cell cancer	0.0031	0.0031	CcSEcCtD
Gadodiamide—Anaphylactic shock—Ifosfamide—germ cell cancer	0.0031	0.0031	CcSEcCtD
Gadodiamide—Oedema—Ifosfamide—germ cell cancer	0.0031	0.0031	CcSEcCtD
Gadodiamide—Chills—Etoposide—germ cell cancer	0.00309	0.00309	CcSEcCtD
Gadodiamide—Anaphylactoid reaction—Methotrexate—germ cell cancer	0.00308	0.00308	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.00308	0.00308	CcSEcCtD
Gadodiamide—Asthenia—Vinblastine—germ cell cancer	0.00308	0.00308	CcSEcCtD
Gadodiamide—Infection—Ifosfamide—germ cell cancer	0.00308	0.00308	CcSEcCtD
Gadodiamide—Tremor—Cisplatin—germ cell cancer	0.00307	0.00307	CcSEcCtD
Gadodiamide—Nervous system disorder—Ifosfamide—germ cell cancer	0.00304	0.00304	CcSEcCtD
Gadodiamide—Ill-defined disorder—Cisplatin—germ cell cancer	0.00304	0.00304	CcSEcCtD
Gadodiamide—Hyperhidrosis—Ifosfamide—germ cell cancer	0.00299	0.00299	CcSEcCtD
Gadodiamide—Feeling abnormal—Bleomycin—germ cell cancer	0.00299	0.00299	CcSEcCtD
Gadodiamide—Malaise—Cisplatin—germ cell cancer	0.00295	0.00295	CcSEcCtD
Gadodiamide—Diarrhoea—Vinblastine—germ cell cancer	0.00294	0.00294	CcSEcCtD
Gadodiamide—Dysgeusia—Etoposide—germ cell cancer	0.00294	0.00294	CcSEcCtD
Gadodiamide—Fatigue—Dactinomycin—germ cell cancer	0.00291	0.00291	CcSEcCtD
Gadodiamide—Hypotension—Ifosfamide—germ cell cancer	0.00289	0.00289	CcSEcCtD
Gadodiamide—Pain—Dactinomycin—germ cell cancer	0.00289	0.00289	CcSEcCtD
Gadodiamide—Urticaria—Bleomycin—germ cell cancer	0.00288	0.00288	CcSEcCtD
Gadodiamide—Body temperature increased—Bleomycin—germ cell cancer	0.00287	0.00287	CcSEcCtD
Gadodiamide—Dizziness—Vinblastine—germ cell cancer	0.00284	0.00284	CcSEcCtD
Gadodiamide—Convulsion—Cisplatin—germ cell cancer	0.00284	0.00284	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	0.00282	0.00282	CcSEcCtD
Gadodiamide—Ataxia—Methotrexate—germ cell cancer	0.0028	0.0028	CcSEcCtD
Gadodiamide—Myalgia—Cisplatin—germ cell cancer	0.00279	0.00279	CcSEcCtD
Gadodiamide—Feeling abnormal—Dactinomycin—germ cell cancer	0.00279	0.00279	CcSEcCtD
Gadodiamide—Paraesthesia—Ifosfamide—germ cell cancer	0.00278	0.00278	CcSEcCtD
Gadodiamide—Ill-defined disorder—Etoposide—germ cell cancer	0.00278	0.00278	CcSEcCtD
Gadodiamide—Anxiety—Cisplatin—germ cell cancer	0.00278	0.00278	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.00276	0.00276	CcSEcCtD
Gadodiamide—Dyspnoea—Ifosfamide—germ cell cancer	0.00276	0.00276	CcSEcCtD
Gadodiamide—Somnolence—Ifosfamide—germ cell cancer	0.00275	0.00275	CcSEcCtD
Gadodiamide—Discomfort—Cisplatin—germ cell cancer	0.00275	0.00275	CcSEcCtD
Gadodiamide—Vomiting—Vinblastine—germ cell cancer	0.00273	0.00273	CcSEcCtD
Gadodiamide—Malaise—Etoposide—germ cell cancer	0.0027	0.0027	CcSEcCtD
Gadodiamide—Headache—Vinblastine—germ cell cancer	0.00269	0.00269	CcSEcCtD
Gadodiamide—Abdominal pain—Dactinomycin—germ cell cancer	0.00267	0.00267	CcSEcCtD
Gadodiamide—Body temperature increased—Dactinomycin—germ cell cancer	0.00267	0.00267	CcSEcCtD
Gadodiamide—Fatigue—Ifosfamide—germ cell cancer	0.00267	0.00267	CcSEcCtD
Gadodiamide—Anaphylactic shock—Cisplatin—germ cell cancer	0.00267	0.00267	CcSEcCtD
Gadodiamide—Oedema—Cisplatin—germ cell cancer	0.00267	0.00267	CcSEcCtD
Gadodiamide—Hypersensitivity—Bleomycin—germ cell cancer	0.00267	0.00267	CcSEcCtD
Gadodiamide—Infection—Cisplatin—germ cell cancer	0.00265	0.00265	CcSEcCtD
Gadodiamide—Pain—Ifosfamide—germ cell cancer	0.00265	0.00265	CcSEcCtD
Gadodiamide—Loss of consciousness—Etoposide—germ cell cancer	0.00263	0.00263	CcSEcCtD
Gadodiamide—Nervous system disorder—Cisplatin—germ cell cancer	0.00262	0.00262	CcSEcCtD
Gadodiamide—Tachycardia—Cisplatin—germ cell cancer	0.00261	0.00261	CcSEcCtD
Gadodiamide—Asthenia—Bleomycin—germ cell cancer	0.0026	0.0026	CcSEcCtD
Gadodiamide—Convulsion—Etoposide—germ cell cancer	0.0026	0.0026	CcSEcCtD
Gadodiamide—Hyperhidrosis—Cisplatin—germ cell cancer	0.00258	0.00258	CcSEcCtD
Gadodiamide—Pruritus—Bleomycin—germ cell cancer	0.00256	0.00256	CcSEcCtD
Gadodiamide—Feeling abnormal—Ifosfamide—germ cell cancer	0.00255	0.00255	CcSEcCtD
Gadodiamide—Chest pain—Etoposide—germ cell cancer	0.00255	0.00255	CcSEcCtD
Gadodiamide—Nausea—Vinblastine—germ cell cancer	0.00255	0.00255	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.00253	0.00253	CcSEcCtD
Gadodiamide—Discomfort—Etoposide—germ cell cancer	0.00252	0.00252	CcSEcCtD
Gadodiamide—Hypotension—Cisplatin—germ cell cancer	0.0025	0.0025	CcSEcCtD
Gadodiamide—Hypersensitivity—Dactinomycin—germ cell cancer	0.00249	0.00249	CcSEcCtD
Gadodiamide—Urticaria—Ifosfamide—germ cell cancer	0.00246	0.00246	CcSEcCtD
Gadodiamide—Body temperature increased—Ifosfamide—germ cell cancer	0.00245	0.00245	CcSEcCtD
Gadodiamide—Abdominal pain—Ifosfamide—germ cell cancer	0.00245	0.00245	CcSEcCtD
Gadodiamide—Anaphylactic shock—Etoposide—germ cell cancer	0.00245	0.00245	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Cisplatin—germ cell cancer	0.00243	0.00243	CcSEcCtD
Gadodiamide—Infection—Etoposide—germ cell cancer	0.00243	0.00243	CcSEcCtD
Gadodiamide—Asthenia—Dactinomycin—germ cell cancer	0.00243	0.00243	CcSEcCtD
Gadodiamide—Paraesthesia—Cisplatin—germ cell cancer	0.0024	0.0024	CcSEcCtD
Gadodiamide—Tachycardia—Etoposide—germ cell cancer	0.00239	0.00239	CcSEcCtD
Gadodiamide—Dyspnoea—Cisplatin—germ cell cancer	0.00238	0.00238	CcSEcCtD
Gadodiamide—Hyperhidrosis—Etoposide—germ cell cancer	0.00237	0.00237	CcSEcCtD
Gadodiamide—Diarrhoea—Dactinomycin—germ cell cancer	0.00231	0.00231	CcSEcCtD
Gadodiamide—Vomiting—Bleomycin—germ cell cancer	0.0023	0.0023	CcSEcCtD
Gadodiamide—Hypotension—Etoposide—germ cell cancer	0.00229	0.00229	CcSEcCtD
Gadodiamide—Rash—Bleomycin—germ cell cancer	0.00229	0.00229	CcSEcCtD
Gadodiamide—Pain—Cisplatin—germ cell cancer	0.00228	0.00228	CcSEcCtD
Gadodiamide—Dermatitis—Bleomycin—germ cell cancer	0.00228	0.00228	CcSEcCtD
Gadodiamide—Hypersensitivity—Ifosfamide—germ cell cancer	0.00228	0.00228	CcSEcCtD
Gadodiamide—Renal failure—Methotrexate—germ cell cancer	0.00226	0.00226	CcSEcCtD
Gadodiamide—Asthenia—Ifosfamide—germ cell cancer	0.00222	0.00222	CcSEcCtD
Gadodiamide—Feeling abnormal—Cisplatin—germ cell cancer	0.0022	0.0022	CcSEcCtD
Gadodiamide—Paraesthesia—Etoposide—germ cell cancer	0.0022	0.0022	CcSEcCtD
Gadodiamide—Pruritus—Ifosfamide—germ cell cancer	0.00219	0.00219	CcSEcCtD
Gadodiamide—Dyspnoea—Etoposide—germ cell cancer	0.00218	0.00218	CcSEcCtD
Gadodiamide—Somnolence—Etoposide—germ cell cancer	0.00217	0.00217	CcSEcCtD
Gadodiamide—Nausea—Bleomycin—germ cell cancer	0.00215	0.00215	CcSEcCtD
Gadodiamide—Vomiting—Dactinomycin—germ cell cancer	0.00215	0.00215	CcSEcCtD
Gadodiamide—Rash—Dactinomycin—germ cell cancer	0.00213	0.00213	CcSEcCtD
Gadodiamide—Diarrhoea—Ifosfamide—germ cell cancer	0.00212	0.00212	CcSEcCtD
Gadodiamide—Body temperature increased—Cisplatin—germ cell cancer	0.00211	0.00211	CcSEcCtD
Gadodiamide—Fatigue—Etoposide—germ cell cancer	0.00211	0.00211	CcSEcCtD
Gadodiamide—Pain—Etoposide—germ cell cancer	0.00209	0.00209	CcSEcCtD
Gadodiamide—Dizziness—Ifosfamide—germ cell cancer	0.00205	0.00205	CcSEcCtD
Gadodiamide—Pharyngitis—Methotrexate—germ cell cancer	0.00205	0.00205	CcSEcCtD
Gadodiamide—Urinary tract disorder—Methotrexate—germ cell cancer	0.00204	0.00204	CcSEcCtD
Gadodiamide—Urethral disorder—Methotrexate—germ cell cancer	0.00202	0.00202	CcSEcCtD
Gadodiamide—Feeling abnormal—Etoposide—germ cell cancer	0.00202	0.00202	CcSEcCtD
Gadodiamide—Nausea—Dactinomycin—germ cell cancer	0.00201	0.00201	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Etoposide—germ cell cancer	0.002	0.002	CcSEcCtD
Gadodiamide—Visual impairment—Methotrexate—germ cell cancer	0.00199	0.00199	CcSEcCtD
Gadodiamide—Vomiting—Ifosfamide—germ cell cancer	0.00197	0.00197	CcSEcCtD
Gadodiamide—Hypersensitivity—Cisplatin—germ cell cancer	0.00197	0.00197	CcSEcCtD
Gadodiamide—Rash—Ifosfamide—germ cell cancer	0.00195	0.00195	CcSEcCtD
Gadodiamide—Dermatitis—Ifosfamide—germ cell cancer	0.00195	0.00195	CcSEcCtD
Gadodiamide—Urticaria—Etoposide—germ cell cancer	0.00194	0.00194	CcSEcCtD
Gadodiamide—Abdominal pain—Etoposide—germ cell cancer	0.00193	0.00193	CcSEcCtD
Gadodiamide—Body temperature increased—Etoposide—germ cell cancer	0.00193	0.00193	CcSEcCtD
Gadodiamide—Tinnitus—Methotrexate—germ cell cancer	0.00192	0.00192	CcSEcCtD
Gadodiamide—Asthenia—Cisplatin—germ cell cancer	0.00192	0.00192	CcSEcCtD
Gadodiamide—Chills—Methotrexate—germ cell cancer	0.00185	0.00185	CcSEcCtD
Gadodiamide—Nausea—Ifosfamide—germ cell cancer	0.00184	0.00184	CcSEcCtD
Gadodiamide—Diarrhoea—Cisplatin—germ cell cancer	0.00183	0.00183	CcSEcCtD
Gadodiamide—Hypersensitivity—Etoposide—germ cell cancer	0.0018	0.0018	CcSEcCtD
Gadodiamide—Dysgeusia—Methotrexate—germ cell cancer	0.00176	0.00176	CcSEcCtD
Gadodiamide—Asthenia—Etoposide—germ cell cancer	0.00176	0.00176	CcSEcCtD
Gadodiamide—Pruritus—Etoposide—germ cell cancer	0.00173	0.00173	CcSEcCtD
Gadodiamide—Vomiting—Cisplatin—germ cell cancer	0.0017	0.0017	CcSEcCtD
Gadodiamide—Rash—Cisplatin—germ cell cancer	0.00168	0.00168	CcSEcCtD
Gadodiamide—Dermatitis—Cisplatin—germ cell cancer	0.00168	0.00168	CcSEcCtD
Gadodiamide—Diarrhoea—Etoposide—germ cell cancer	0.00167	0.00167	CcSEcCtD
Gadodiamide—Ill-defined disorder—Methotrexate—germ cell cancer	0.00167	0.00167	CcSEcCtD
Gadodiamide—Malaise—Methotrexate—germ cell cancer	0.00162	0.00162	CcSEcCtD
Gadodiamide—Dizziness—Etoposide—germ cell cancer	0.00162	0.00162	CcSEcCtD
Gadodiamide—Nausea—Cisplatin—germ cell cancer	0.00159	0.00159	CcSEcCtD
Gadodiamide—Convulsion—Methotrexate—germ cell cancer	0.00156	0.00156	CcSEcCtD
Gadodiamide—Vomiting—Etoposide—germ cell cancer	0.00156	0.00156	CcSEcCtD
Gadodiamide—Rash—Etoposide—germ cell cancer	0.00154	0.00154	CcSEcCtD
Gadodiamide—Dermatitis—Etoposide—germ cell cancer	0.00154	0.00154	CcSEcCtD
Gadodiamide—Headache—Etoposide—germ cell cancer	0.00153	0.00153	CcSEcCtD
Gadodiamide—Chest pain—Methotrexate—germ cell cancer	0.00153	0.00153	CcSEcCtD
Gadodiamide—Myalgia—Methotrexate—germ cell cancer	0.00153	0.00153	CcSEcCtD
Gadodiamide—Arthralgia—Methotrexate—germ cell cancer	0.00153	0.00153	CcSEcCtD
Gadodiamide—Discomfort—Methotrexate—germ cell cancer	0.00151	0.00151	CcSEcCtD
Gadodiamide—Anaphylactic shock—Methotrexate—germ cell cancer	0.00147	0.00147	CcSEcCtD
Gadodiamide—Infection—Methotrexate—germ cell cancer	0.00146	0.00146	CcSEcCtD
Gadodiamide—Nausea—Etoposide—germ cell cancer	0.00145	0.00145	CcSEcCtD
Gadodiamide—Nervous system disorder—Methotrexate—germ cell cancer	0.00144	0.00144	CcSEcCtD
Gadodiamide—Hyperhidrosis—Methotrexate—germ cell cancer	0.00142	0.00142	CcSEcCtD
Gadodiamide—Hypotension—Methotrexate—germ cell cancer	0.00137	0.00137	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Methotrexate—germ cell cancer	0.00134	0.00134	CcSEcCtD
Gadodiamide—Paraesthesia—Methotrexate—germ cell cancer	0.00132	0.00132	CcSEcCtD
Gadodiamide—Dyspnoea—Methotrexate—germ cell cancer	0.00131	0.00131	CcSEcCtD
Gadodiamide—Somnolence—Methotrexate—germ cell cancer	0.0013	0.0013	CcSEcCtD
Gadodiamide—Dyspepsia—Methotrexate—germ cell cancer	0.00129	0.00129	CcSEcCtD
Gadodiamide—Fatigue—Methotrexate—germ cell cancer	0.00126	0.00126	CcSEcCtD
Gadodiamide—Pain—Methotrexate—germ cell cancer	0.00125	0.00125	CcSEcCtD
Gadodiamide—Feeling abnormal—Methotrexate—germ cell cancer	0.00121	0.00121	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Methotrexate—germ cell cancer	0.0012	0.0012	CcSEcCtD
Gadodiamide—Urticaria—Methotrexate—germ cell cancer	0.00116	0.00116	CcSEcCtD
Gadodiamide—Abdominal pain—Methotrexate—germ cell cancer	0.00116	0.00116	CcSEcCtD
Gadodiamide—Body temperature increased—Methotrexate—germ cell cancer	0.00116	0.00116	CcSEcCtD
Gadodiamide—Hypersensitivity—Methotrexate—germ cell cancer	0.00108	0.00108	CcSEcCtD
Gadodiamide—Asthenia—Methotrexate—germ cell cancer	0.00105	0.00105	CcSEcCtD
Gadodiamide—Pruritus—Methotrexate—germ cell cancer	0.00104	0.00104	CcSEcCtD
Gadodiamide—Diarrhoea—Methotrexate—germ cell cancer	0.001	0.001	CcSEcCtD
Gadodiamide—Dizziness—Methotrexate—germ cell cancer	0.000969	0.000969	CcSEcCtD
Gadodiamide—Vomiting—Methotrexate—germ cell cancer	0.000932	0.000932	CcSEcCtD
Gadodiamide—Rash—Methotrexate—germ cell cancer	0.000924	0.000924	CcSEcCtD
Gadodiamide—Dermatitis—Methotrexate—germ cell cancer	0.000923	0.000923	CcSEcCtD
Gadodiamide—Headache—Methotrexate—germ cell cancer	0.000918	0.000918	CcSEcCtD
Gadodiamide—Nausea—Methotrexate—germ cell cancer	0.00087	0.00087	CcSEcCtD
